Scinai Immunotherapeutics (2F50) Q3 2020 Earnings Report
0 Followers
DE:2F50 Q3 2020 EPS Results
- Actual EPS
- -EUR 32.72
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 2.68
DE:2F50 Q3 2020 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2020
- Date
- 01/28/2021
- Time
- After Close
- Conference Call
- Thursday, January 28, 2021
DE:2F50 Upcoming Earnings
Scinai Immunotherapeutics's next earnings date is estimated for May 13, 2027, based on past reporting schedules.
Q3 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2F50 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 13, 2027 | 2026 (Q4) | ―- | 8.54 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―-2.48 | -42.3 | 94.14% (+39.83) | |
| Aug 20, 2026 | 2026 (Q2) | ―-3.27 | -15.67 | 79.16% (+12.41) | |
| Jun 10, 2026 | 2026 (Q1) | ―0.00 | -7.1 | 100.00% (+7.10) | |
| Apr 01, 2026 | 2025 (Q4) | ―8.54 | -7.1 | 220.31% (+15.64) | |
| Dec 02, 2025 | 2025 (Q3) | ―-42.30 | 0.02 | -225919.05% (-42.32) | |
| Sep 02, 2025 | 2025 (Q2) | ―-15.67 | -0.02 | -87750.00% (-15.66) | |
| May 30, 2025 | 2025 (Q1) | ―-1.07 | -0.01 | -11840.00% (-1.06) | |
| May 07, 2025 | 2024 (Q4) | ―-7.10 | -0.01 | -79480.00% (-7.09) | |
| Nov 22, 2024 | 2024 (Q3) | ―0.02 | 0.18 | -89.50% (-0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
